Literature DB >> 10501357

High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group.

F P Cappuccio1, E Meilahn, J M Zmuda, J A Cauley.   

Abstract

BACKGROUND: High blood pressure is associated with abnormalities in calcium metabolism. Sustained calcium loss may lead to increased bone-mineral loss in people with high blood pressure. We investigated the prospective association between blood pressure and bone-mineral loss over time in elderly white women.
METHODS: We studied 3676 women who were initially assessed in 1988-90 (mean age 73 years [SD 4, range 66-91 years]; mean bodyweight 65.3 kg [11.5]; blood pressure 137/75 mm Hg [17/9]) who were not on thiazide diuretics. Mean follow-up was 3.5 years. Anthropometry, blood pressure, and bone-mineral density at the femoral neck were measured at baseline and bone densitometry was repeated after 3.5 years by dual-energy X-ray absorptiometry.
FINDINGS: After adjustment for age, initial bone-mineral density, weight and weight change, smoking, and regular use of hormone-replacement therapy, the rate of bone loss at the femoral neck increased with blood pressure at baseline. In the quartiles of systolic blood pressure, yearly bone losses increased from 2.26 mg/cm2 (95% CI 1.48-3.04) in the first quartile to 3.79 mg/cm2 in the fourth quartile (3.13-4.45; test for heterogeneity, p=0.03; test for linear trend, p=0.01), equivalent to yearly changes of 0.34% (0.20-0.46) and 0.59% (0.49-0.69; test for heterogeneity, p=0.02; test for linear trend, p=0.005). There was no significant interaction with age. The exclusion of women on antihypertensive drugs did not alter the results. For diastolic blood pressure, there was an association with bone loss in women younger than 75 years.
INTERPRETATION: Higher blood pressure in elderly white women is associated with increased bone loss at the femoral neck. This association may reflect greater calcium losses associated with high blood pressure, which may contribute to the risk of hip fractures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501357     DOI: 10.1016/s0140-6736(99)01437-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

Review 1.  The DASH trials implicate dysfunction in calcium regulation in the pathogenesis of human hypertension.

Authors:  A G Logan
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.

Authors:  W F Rodrigues; M F M Madeira; T A da Silva; J T Clemente-Napimoga; C B Miguel; V J Dias-da-Silva; O Barbosa-Neto; A H Lopes; M H Napimoga
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study.

Authors:  L A Ahmed; H Schirmer; G K Berntsen; V Fønnebø; R M Joakimsen
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

4.  Myocardial infarction risk among patients with fractures receiving bisphosphonates.

Authors:  Cory B Pittman; Lisa A Davis; Angelique L Zeringue; Liron Caplan; Kent R Wehmeier; Jeffrey F Scherrer; Hong Xian; Francesca E Cunningham; Jay R McDonald; Alexis Arnold; Seth A Eisen
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

5.  Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men.

Authors:  Nahid Rianon; Catherine G Ambrose; Hannah Pervin; Melissa Garcia; Scherezade K Mama; Ann V Schwartz; Brendan Lee; Tamara Harris
Journal:  Arch Osteoporos       Date:  2017-10-28       Impact factor: 2.617

6.  Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.

Authors:  L Zhou; J Song; S Yang; S Meng; X Lv; J Yue; A Mina; B Puchi; Y Geng; L Yang
Journal:  Osteoporos Int       Date:  2017-02-02       Impact factor: 4.507

7.  Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.

Authors:  Takahiro Tokuda; Junichi Hasegawa; Akiko Matsuda; Hiroshi Hagino
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

8.  Age at natural menopause and risk of ischemic stroke: the Framingham heart study.

Authors:  Lynda D Lisabeth; Alexa S Beiser; Devin L Brown; Joanne M Murabito; Margaret Kelly-Hayes; Philip A Wolf
Journal:  Stroke       Date:  2009-02-20       Impact factor: 7.914

9.  Multisystem dysregulation and bone strength: findings from the study of midlife in the United States.

Authors:  Takahiro Mori; Arun S Karlamangla; Sharon Stein Merkin; Carolyn J Crandall; Neil Binkley; Gail A Greendale; Teresa E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

10.  Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study.

Authors:  Qihong Sun; Yu Zheng; Kang Chen; Wenhua Yan; Juming Lu; Jingtao Dou; Zhaohui Lv; Baoan Wang; Weijun Gu; Jianming Ba; Yiming Mu
Journal:  Clin Exp Med       Date:  2015-11-29       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.